Scribe Therapeutics Inc. Share Price
NASDAQ: SCTXScribe Therapeutics Inc. Stock Performance
Scribe Therapeutics Inc. Share Price Today
As of 15 October 2026, Scribe Therapeutics Inc.'s share price is $20.86. The stock opened at $19.09, compared to its previous close of $19.06. During today's trading session, Scribe Therapeutics Inc.'s share price traded between $19.09 and $21.89, with an average price of $20.49. Over the past 52 weeks, the stock has recorded a high of $39.20 and a low of $13.51. In terms of performance, Scribe Therapeutics Inc.'s share price has risen by 8.56% over the last six months and is up 8.56% on a year-on-year basis.
Scribe Therapeutics Inc. Share Price Chart
About Scribe Therapeutics Inc.
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Scribe Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $18.87 | $20.84 | +13.05% |
Sep 2026 | $29.40 | $18.43 | -35.12% |
Aug 2026 | $19.86 | $28.41 | +47.84% |
Jul 2026 | $24.75 | $19.22 | N/A |